OABI - שווי כולל של החברה OmniAb Inc

OmniAb, Inc. (OABI) possesses high macro-resilience due to long-term medical agreements, with revenues based on payments from pharma behemoths. Effective management is successfully implementing a licensing model, ensuring high operating profitability. This chart reflects a current share price of 709.86, while the company minimizes risks by utilizing an AI platform for antibody creation and receiving royalties from numerous medicinal drugs.

Enterprise value combines market capitalization with net debt, determining the actual cost of a full business buyout while eliminating accounting distortions. By analyzing the calculated enterprise value, an investor assesses the financial stability of OmniAb, Inc., where a cloud outsourcing strategy for AI systems minimizes infrastructure capital expenditures, preventing asset inflation and the risk of technological dependency.